simvastatin has been researched along with Peripheral Arterial Disease in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (92.31) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Adam, L; Baumgartner, I; Dopheide, JF; Drexel, H; Kaspar, M; Papac, L; Ramadani, H; Rastan, A; Veit, J; Vonbank, A | 1 |
| Ballantyne, CM; Baum, SJ; Davidson, MH; Koren, A; Langslet, G; Mandel, J; McCullough, PA; Sanganalmath, SK; Shah, PK | 1 |
| Drummond, ID; Turtle, EJ; Webb, DJ | 1 |
| Ballantyne, CM; Brunner, G; Chen, C; Dong, JF; Hoogeveen, RC; Kougias, P; Kumar, A; Lin, PH; Lumsden, AB; Morrisett, JD; Murray, T; Nambi, V; Negi, SI; Sun, W; Taylor, A; Virani, SS; Yang, EY | 1 |
| Kasprzak, M; Majewski, W; Pioruńska-Stolzmann, M; Strzyżewski, KW; Strzyżewski, W | 1 |
| Boekholdt, SM; Fayyad, R; Hovingh, GK; Laskey, R; Pedersen, TR; Stoekenbroek, RM; Tikkanen, MJ | 1 |
| Bonaca, MP; Creager, MA | 1 |
| Amrein, K; Binder, J; Cvirn, G; Ferstl, U; Froehlich, H; Hallström, S; Hörl, G; Jürgens, G; Koidl, C; Ledinski, G; Scharnagl, H; Stojakovic, T; Tafeit, E; Trauner, M | 1 |
| Acin, F; Bleda, S; de Haro, J; Ferruelo, A; Lopez de Maturana, I; Varela, C | 1 |
| Anderson, JD; Berr, SS; Chew, JD; Christopher, JM; DiMaria, JM; Epstein, FH; Hagspiel, KD; Harthun, NL; Hunter, JR; Kramer, CM; Meyer, CH; Wang, H; West, AM; Winberry, GB | 1 |
| Jones, WS; Krucoff, MW; Patel, MR | 1 |
| Anderson, JD; Berr, SS; Christopher, JM; Dimaria, JM; Epstein, FH; Hagspiel, KD; Harthun, NL; Hunter, JR; Kramer, CM; Meyer, CH; Wang, H; Weltman, AL; West, AM | 1 |
| Krysiak, R; Okopien, B | 1 |
1 review(s) available for simvastatin and Peripheral Arterial Disease
| Article | Year |
|---|---|
Pharmacological treatment and current management of peripheral artery disease.
Topics: Atorvastatin; Exercise; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Life Style; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Pyrroles; Simvastatin; Smoking Cessation; Treatment Outcome | 2015 |
5 trial(s) available for simvastatin and Peripheral Arterial Disease
| Article | Year |
|---|---|
The Effect of Lipid Modification on Peripheral Artery Disease after Endovascular Intervention Trial (ELIMIT).
Topics: Aged; Azetidines; Cholesterol; Double-Blind Method; Endothelium, Vascular; Ezetimibe; Female; Femoral Artery; Humans; Lipids; Lipoproteins; Magnetic Resonance Imaging; Male; Middle Aged; Niacin; Peripheral Arterial Disease; Simvastatin | 2013 |
High-dose atorvastatin is superior to moderate-dose simvastatin in preventing peripheral arterial disease.
Topics: Aged; Atorvastatin; Cholesterol, LDL; Dose-Response Relationship, Drug; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Netherlands; Peripheral Arterial Disease; Prospective Studies; Pyrroles; Scandinavian and Nordic Countries; Simvastatin | 2015 |
The effect of ezetimibe on peripheral arterial atherosclerosis depends upon statin use at baseline.
Topics: Aged; Anticholesteremic Agents; Atherosclerosis; Azetidines; Cholesterol, LDL; Double-Blind Method; Ezetimibe; Female; Femoral Artery; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Magnetic Resonance Imaging; Male; Middle Aged; Peripheral Arterial Disease; Plaque, Atherosclerotic; Prospective Studies; Simvastatin; Treatment Outcome | 2011 |
Low-density lipoprotein lowering does not improve calf muscle perfusion, energetics, or exercise performance in peripheral arterial disease.
Topics: Aged; Anticholesteremic Agents; Azetidines; Cholesterol, LDL; Energy Metabolism; Exercise Test; Exercise Tolerance; Ezetimibe; Female; Humans; Leg; Magnetic Resonance Angiography; Magnetic Resonance Spectroscopy; Male; Middle Aged; Muscle, Skeletal; Peripheral Arterial Disease; Phosphocreatine; Simvastatin | 2011 |
Monocyte-suppressing effects of simvastatin in patients with isolated hypertriglyceridemia.
Topics: Adult; Biological Availability; Blood Glucose; C-Reactive Protein; Cell Physiological Phenomena; Cytokines; Female; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Inflammation; Lipids; Male; Middle Aged; Monocytes; Peripheral Arterial Disease; Simvastatin; Treatment Outcome | 2013 |
7 other study(ies) available for simvastatin and Peripheral Arterial Disease
| Article | Year |
|---|---|
Adherence to statin therapy favours survival of patients with symptomatic peripheral artery disease.
Topics: Cholesterol, LDL; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Peripheral Arterial Disease; Simvastatin | 2021 |
Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials).
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Atherosclerosis; Atorvastatin; Cholesterol, LDL; Clinical Trials, Phase III as Topic; Coronary Disease; Drug Therapy, Combination; Female; Heterozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipoproteinemia Type II; Male; Maximum Tolerated Dose; Middle Aged; PCSK9 Inhibitors; Peripheral Arterial Disease; Risk; Rosuvastatin Calcium; Simvastatin; Stroke; Treatment Outcome | 2018 |
Improvement in symptoms of peripheral arterial disease with sildenafil therapy.
Topics: Anticholesteremic Agents; Erectile Dysfunction; Exercise Therapy; Humans; Intermittent Claudication; Male; Middle Aged; Peripheral Arterial Disease; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Scotland; Sildenafil Citrate; Simvastatin; Sulfones; Treatment Outcome; Walking | 2013 |
Effect of surgical treatment on lipid peroxidation parameters and antioxidant status in the serum of patients with peripheral arterial disease.
Topics: Aged; Anticholesteremic Agents; Antioxidants; Ceruloplasmin; Humans; Lipid Peroxidation; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Peripheral Arterial Disease; Postoperative Period; Simvastatin | 2013 |
Simvastatin Efficiently Lowers Small LDL-IgG Immune Complex Levels: A Therapeutic Quality beyond the Lipid-Lowering Effect.
Topics: Adult; Aged; Aged, 80 and over; Antigen-Antibody Complex; Apolipoproteins B; Cholesterol, LDL; Coronary Artery Disease; Coronary Restenosis; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin G; Male; Malondialdehyde; Middle Aged; Peripheral Arterial Disease; Simvastatin | 2016 |
Effect of Simvastatin Treatment on "In Vitro" NLRP1 Inflammasome Expression in Peripheral Arterial Disease.
Topics: Adaptor Proteins, Signal Transducing; Aged; Anti-Inflammatory Agents; Apoptosis Regulatory Proteins; Case-Control Studies; Cells, Cultured; Critical Illness; Endothelial Cells; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammasomes; Ischemia; Male; Middle Aged; NLR Proteins; Peripheral Arterial Disease; Simvastatin; Transcription, Genetic; Up-Regulation | 2016 |
Learning to walk before we run: the mechanics of medical intervention for peripheral arterial disease.
Topics: Anticholesteremic Agents; Azetidines; Ezetimibe; Female; Humans; Leg; Male; Peripheral Arterial Disease; Simvastatin | 2011 |